News
ALD: Availability of the 2021 Universal Registration Document
PRESS RELEASE BY KAUFMAN & BROAD FOLLOWING THE CROSSING BY PROMOGIM OF THE 20% THRESHOLDS OF THE SHARE CAPITAL AND VOTING RIGHTS OF THE COMPANY
Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022
Regulatory News:
Median Technologies (Euronext Growth - ALMDT) (Paris:ALMDT) whose Board of Directors met on April 20, 2022 to close the consolidated financial statements for the year ending
Sensorion Will Participate in Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit Held Virtually on April 26, 2022
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
Mexikanisches Telekommunikationsunternehmen Megacable wählt Verimatrix Streamkeeper und XTD-Lösungen zur weiteren Stärkung der Sicherheit
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, teilte heute mit, dass Megacable, eines der größten
Mexico’s Megacable Selects Verimatrix Streamkeeper and XTD Products To Further Strengthen Security
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Megacable, one of Mexico’s
ROCTOOL: Saint-Gobain and Roctool combine their unique technologies to boost the composite and thermoplastic 3D textile preform parts manufacturing
Sensorion to Attend the Kempen Life Sciences, Cell & Gene Meeting on the Mediterranean Conferences in April 2022
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3
Regulatory News:
NANOBOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for
Verimatrix kündigt Teilnahme an drei NAB Show-Sitzungen vom 24. bis 26. April in Las Vegas an
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, hat heute die folgenden NAB Show-Sitzungen im Las Vegas
Poxel Announces PXL770 Awarded FDA Fast Track Designation for X-linked Adrenoleukodystrophy
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Verimatrix Announces Participation in Three NAB Show Sessions, April 24-26 in Las Vegas
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the following NAB Show sessions taking place
NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities
Transgene to Present New Positive Preliminary Phase I Clinical Data at AACR 2022, Reinforcing the Potential of TG4050
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, will present additional positive
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.P
Website
ABIONYX Pharma Reports Positive Interim Results From Phase 2a Clinical Trial Evaluating CER-001 in the Treatment of Septic Patients at High Risk of Developing Acute Kidney Injury
Regulatory News:
ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today
Cybertrust implementiert IoT-Sicherheit von Verimatrix für Kunden in ganz Japan
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass die in Tokio ansässige Cybertrust Co.,
ESI Group beruft Florence Barré zur Stabschefin und zum Mitglied des Führungsteams
ESI Group (ISIN Code: FR0004110310, Symbol: ESI), ein weltweiter Softwarepartner der Industrie für Simulation und virtuelles Prototyping, beruft Florence Barré mit Wirkung vom 29. März 2022 zur
Cybertrust Deploys Verimatrix IoT Security for Customers Across Japan
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Tokyo-based Cybertrust Co., Ltd. began
ESI Group Appoints Florence Barré Chief of Staff and Member of the Leadership Team
Regulatory News:
ESI Group (ISIN Code: FR0004110310, Symbol: ESI), a global simulation and virtual prototyping software partner for the industry, appoints Florence Barré as Chief of Staff to
Transgene: Availability of Preparatory Documents for the Combined General Meeting of May 25, 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined
GAUSSIN Announces the Start of Delivery of 36 APM 75T HE Electric Tractors, 24 POWERPACKS LMP® and 6 Charging Stations Ordered by CÔTE D'IVOIRE TERMINAL
GAUSSIN (EURONEXT GROWTH ALGAU - FR0013495298), a pioneer in the clean and intelligent transport of goods and people, announces it has started delivering on the order of 36 APM 75T HE electric
Teleperformance Partners with UNICEF in Support of Child Education and Global Disaster Relief
Regulatory News:
Teleperformance (Paris:TEP), the global leader in outsourced customer and citizen experience management and advanced related services, today announced a US$6 million global
Die Bedrohungsabwehr von Verimatrix ermöglicht Capri Healthcare die sichere Digitalisierung der Arzt-Patienten-Betreuung
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass Capri Healthcare sich für App Shield von Verimatrix